Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2009
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009CA2723421A1 Chemical compounds
11/18/2009EP2119707A1 Composition for treatment of undifferentiated-type of gastric cancer
11/18/2009EP2119476A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/18/2009EP2118063A1 A method for the preparation of montelukast
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1306372B1 Heterocycle derivatives and drugs
11/18/2009CN101583597A Sulfonamide derivatives as liver carnitine palmitoyl transferase (L-CPT1)
11/18/2009CN101580602A Production method of spherical high-content rubber antioxidant RD
11/18/2009CN101580520A Novel organic electroluminescent compound and electroluminescent device using the same
11/18/2009CN101580451A Novel organic electroluminescent compound and electroluminescent device using the same
11/18/2009CN101579344A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009CN101579343A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/18/2009CN100560569C Lotus plumule alkaloid extract and its preparation process and use in preparation of drugs for cardiovascular and cerebrovascular diseases
11/17/2009US7619091 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052)
11/17/2009US7619090 Polymerization catalyst for polymerization of alpha-olefins
11/17/2009US7618965 (Arylamidoanilino)nitroethylene compounds
11/17/2009US7618963 Bicyclic heteroaromatic compounds
11/17/2009US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/12/2009WO2009137412A1 Therapeutic compounds
11/12/2009WO2009137411A1 Therapeutic compounds
11/12/2009WO2009136646A1 Method for producing unsaturated organic compound
11/12/2009WO2009136596A1 Organic electroluminescent element
11/12/2009WO2009135579A1 Polymorph of 8-hydroxy-5- [(1r)-1-hydroxy-2- [[(1r) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1h)-quinolinone monohydrochloride
11/12/2009WO2009135577A1 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)- quinolinone monohydrochloride
11/12/2009US20090281323 Process for the manufacture of montelukast sodium
11/12/2009US20090281142 Thiazole derivative
11/12/2009US20090281133 Heterocyclic antiviral compounds
11/12/2009US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/12/2009US20090281103 Renin Inhibitors
11/12/2009US20090280982 Quinolinylmethyl Compounds
11/12/2009US20090280068 Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009US20090280067 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009US20090278118 Benzofluoranthene compound and organic light-emitting device using the compound
11/12/2009DE102008022221A1 Inhibitoren der humanen Aldosteronsynthase CYP11B2 Inhibitors of human aldosterone synthase CYP11B2
11/11/2009EP2116537A1 Polymorph of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
11/11/2009EP2116536A1 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)- quinolinone monohydrochloride
11/11/2009EP2116534A1 Process for production of binuclear metal complex
11/11/2009EP2116246A1 Composition for treatment of pancreatic cancer
11/11/2009EP2114889A1 Method of preparing montelukast and intermediates used therein
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1477186B1 Antipruritics
11/11/2009CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/11/2009CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
11/10/2009US7615640 Merocyanine dyes; solar cells
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009CA2372763C New process
11/05/2009WO2009133468A1 Improved process for preparing quinoline-3-carboxamide derivatives
11/05/2009WO2009132593A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof
11/05/2009WO2009050284A3 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
11/05/2009US20090275752 Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof
11/05/2009US20090275612 Compound With Antimalarial Activity And Antimalarial Drug Containing The Same As Active Ingredient
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275524 Novel hypocholesterolemic compounds
11/05/2009US20090274652 Hepatitis C Virus Inhibitors
11/04/2009EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009EP2113031A1 Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
11/04/2009EP1844045B1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/04/2009CN101570510A Quinoline compound, pharmaceutical composition, preparation method and application thereof
11/03/2009US7612208 Has excellent characteristics in terms of physical properties (particularly, dissolution rate) and pharmacokinetics (particularly, bioavailability), and is extremely useful as an angiogenesis inhibitor or c-Kit kinase inhibitor
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612091 Caspase inhibitors and uses thereof
11/03/2009CA2485580C Process for producing optically active oxoheptenoic acid ester
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
10/2009
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130056A1 Process for making montelukast intermediates
10/29/2009WO2009129573A1 Nicotinamide derivatives
10/29/2009WO2009109493A3 2-aminoquinoline derivatives as 5-ht ( 5a) receptor antagonists
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270628 Process for making montelukast intermediates
10/29/2009US20090270627 4-Ethynyl (1,2-dicyanobenzene)-4'-Ethynylphenyl-1(4,5-dicyanobenzene); 1,4-Bis(4-pyridyl)butadiyne; 4-ethynyl(pyridine)-4'-ethynylnaphthalene-1-pyridine; self-assembled mono-, multilayers/ supramolecular objects; three-terminal devices; logic switches;nanoelectronic ; computers; wires; dielectrics
10/29/2009US20090270450 Chemical compounds
10/29/2009US20090270408 Amide derivatives as positive allosteric modulators and methods of use thereof
10/29/2009US20090270371 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009CA2753532A1 Nicotinamide derivatives
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/28/2009EP2112138A1 Onium salts and their use for detecting and dosing metals
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009CN101568524A Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
10/28/2009CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608628 Alkylsulphonamide quinolines
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/27/2009CA2243474C Quinolin-2-(1h)-ones
10/22/2009WO2009128262A1 Quinolone derivative and use thereof
10/22/2009WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009WO2009127417A1 Quinoline derivatives as axl kinase inhibitors
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 277